{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T21:40:18Z","timestamp":1768513218721,"version":"3.49.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T00:00:00Z","timestamp":1748822400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T00:00:00Z","timestamp":1748822400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Department of Microbiology and Immunology, School of Medical Sciences, College of Health and Allied Sciences, University of Cape Coast, Cape Coast, Ghana"},{"name":"Samuel and Emelia Brew Butler School of Graduate Studies, UCC Research Grant"},{"name":"AMED Team of the Virology Department, Noguchi Memorial Institute for Medical Research, University of Ghana"},{"name":"Freely given aid by Prof. Joseph Humphrey Kofi Bonney"},{"name":"Freely given aid by Nicholas Thomford"},{"name":"Freely given aid by Wishwell Pomeyie"},{"name":"Freely given aid by Francis Abrokwah"},{"name":"Freely given aid by Selina Appiah"},{"name":"Freely given aid by Alexander Owusu-Ansah"},{"name":"Freely given aid by Dr. Prince Amoah Barnie"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"DOI":"10.1186\/s12879-025-11135-7","type":"journal-article","created":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T09:23:13Z","timestamp":1748856193000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["HIV-1 diagnostic, prognostic and ART-resistance detection potential of selected MiRNAs"],"prefix":"10.1186","volume":"25","author":[{"given":"Karen","family":"Pomeyie","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph Humphrey Kofi","family":"Bonney","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benjamin","family":"Amoani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roland Osei","family":"Saahene","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicholas Ekow","family":"Thomford","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wishwell","family":"Pomeyie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francis","family":"Abrokwah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helena","family":"Quayson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salisu Kalaamullah","family":"Musah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Selina","family":"Appiah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deborah","family":"Pratt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Magdalene Sarah","family":"Ofori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander","family":"Owusu-Ansah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Prince Amoah","family":"Barnie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,6,2]]},"reference":[{"key":"11135_CR1","unstructured":"World Health Organisation. Global health sector strategies on, respectively, HIV, viral hepatitis and sexually transmitted infections for the period 2022\u20132030. World Health Organization; 2022."},{"issue":"1","key":"11135_CR2","first-page":"491","volume":"8","author":"PK Mozhi","year":"2021","unstructured":"Mozhi PK, Ganapathy D. Awareness of structural biology of Hiv among dental students. Eur J Mol Clin Med. 2021;8(1):491\u2013503.","journal-title":"Eur J Mol Clin Med"},{"key":"11135_CR3","unstructured":"Obiri-Yeboah D. Elucidating Sexually Transmitted Infections, Second Edition. 2020."},{"key":"11135_CR4","doi-asserted-by":"crossref","unstructured":"Bystryak S, Acharya CJCCA. Detection of HIV-1 p24 antigen in patients with varying degrees of viremia using an ELISA with a photochemical signal amplification system. Clin Chim Acta. 2016;456:128\u201336.","DOI":"10.1016\/j.cca.2016.02.022"},{"key":"11135_CR5","doi-asserted-by":"crossref","unstructured":"Tran T, Montano M, MicroRNAs. Mirrors of health and disease. Translating MicroRNAs to the Clinic: Elsevier; 2017. pp. 1\u201315.","DOI":"10.1016\/B978-0-12-800553-8.00001-9"},{"key":"11135_CR6","doi-asserted-by":"crossref","unstructured":"O\u2019Brien J, Hayder H, Zayed Y, Peng CJF. Overview of MicroRNA biogenesis, mechanisms of actions, and circulation. Front Endocrinol. 2018;9:402.","DOI":"10.3389\/fendo.2018.00402"},{"key":"11135_CR7","doi-asserted-by":"crossref","unstructured":"Devadas K, Biswas S, Haleyurgirisetty M, Ragupathy V, Wang X, Lee S, et al. Identification of host micro RNAs that differentiate HIV-1 and HIV-2 infection using genome expression profiling techniques. Viruses. 2016;8(5):121.","DOI":"10.3390\/v8050121"},{"key":"11135_CR8","doi-asserted-by":"crossref","unstructured":"Biswas S, Chen E, Haleyurgirisetty M, Lee S, Hewlett I, Devadas KJI. Comparison of MiRNA expression profiles between HIV-1 and HIV-2 infected Monocyte-Derived macrophages (MDMs) and peripheral blood mononuclear cells (PBMCs). Int J Molec Sci. 2020;21(18):6970.","DOI":"10.3390\/ijms21186970"},{"key":"11135_CR9","doi-asserted-by":"crossref","unstructured":"Qi Y, Hu H, Guo H, Xu P, Shi Z, Huan X, et al. MicroRNA profiling in plasma of HIV-1 infected patients: potential markers of infection and immune status. J Publ Health Emerg. 2017;1(7):1\u201313.","DOI":"10.21037\/jphe.2017.05.11"},{"key":"11135_CR10","doi-asserted-by":"crossref","unstructured":"Bazi\u00e9 WW, Boucher J, Goyer B, Traore IT, Kania D, Som\u00e9 DY, et al. Plasma vesicular miR-155 as a biomarker of immune activation in antiretroviral treated people living with HIV. Front Immunol. 2022;13:916599.","DOI":"10.3389\/fimmu.2022.916599"},{"key":"11135_CR11","doi-asserted-by":"crossref","unstructured":"Dessie ZG, Zewotir T, Mwambi H, North DJB. Modelling of viral load dynamics and CD4 cell count progression in an antiretroviral Naive cohort: using a joint linear mixed and multistate Markov model. BMC Infect Dis. 2020;20:1\u201314.","DOI":"10.1186\/s12879-020-04972-1"},{"key":"11135_CR12","doi-asserted-by":"crossref","unstructured":"Rashid F, Zaongo SD, Song F, Chen YJFI. The diverse roles of MiRNAs in HIV pathogenesis: current Understanding and future perspectives. Front Immunol. 2023;13:1091543.","DOI":"10.3389\/fimmu.2022.1091543"},{"key":"11135_CR13","doi-asserted-by":"crossref","unstructured":"Bazi\u00e9 WW, Boucher J, Traor\u00e9 IT, Kania D, Som\u00e9 DY, Alary M, et al. Vesicular MicroRNA as Potential Biomarkers Viral Rebound. Cells; 2022;11(5):85","DOI":"10.3390\/cells11050859"},{"key":"11135_CR14","doi-asserted-by":"crossref","unstructured":"Marquez-Pedroza J, C\u00e1rdenas-Bedoya J, Mor\u00e1n-Moguel MC, Escoto-Delgadillo M, Torres-Mendoza BM, P\u00e9rez-R\u00edos AM, et al. Plasma MicroRNA expression levels in HIV-1-positive patients receiving antiretroviral therapy. Biosci Rep. 2020;40(5).","DOI":"10.1042\/BSR20194433"},{"key":"11135_CR15","doi-asserted-by":"crossref","unstructured":"Ali H, Amoyaw F, Baden D, Durand L, Bronson M, Kim A, et al. Ghana\u2019s HIV epidemic and PEPFAR\u2019s contribution towards epidemic control. Ghana Med J. 2019;53(1):59\u201362.","DOI":"10.4314\/gmj.v53i1.9"},{"key":"11135_CR16","doi-asserted-by":"crossref","unstructured":"Aftab M, Poojary SS, Seshan V, Kumar S, Agarwal P, Tandon S, et al. Urine MiRNA signature as a potential non-invasive diagnostic and prognostic biomarker in cervical cancer. Sci Rep. 2021;11(1):1\u201313.","DOI":"10.1038\/s41598-021-89388-w"},{"key":"11135_CR17","doi-asserted-by":"crossref","unstructured":"Livak KJ, Schmittgen TDJ. Analysis of relative gene expression data using real-time quantitative PCR and the 2 \u2013 \u2206\u2206CT method. Methods. 2001;25(4):402\u20138.","DOI":"10.1006\/meth.2001.1262"},{"key":"11135_CR18","doi-asserted-by":"crossref","unstructured":"Schmittgen TD, Livak KJJN. Analyzing real-time PCR data by the comparative CT method. Nat Protocol. 2008;3(6):1101\u20138.","DOI":"10.1038\/nprot.2008.73"},{"key":"11135_CR19","doi-asserted-by":"crossref","unstructured":"Cuesta-Sancho S, M\u00e1rquez-Ruiz D, Illanes-\u00c1lvarez F, Campa\u00f1a-G\u00f3mez I, Mart\u00edn-Aspas A, Trujillo-Soto MT, et al. Expression profile of MicroRNAs related with viral infectivity, inflammatory response, and immune activation in people living with HIV. Front Microbiol. 2023;14.","DOI":"10.3389\/fmicb.2023.1136718"},{"key":"11135_CR20","doi-asserted-by":"crossref","unstructured":"Hosmer DW Jr, Lemeshow S, Sturdivant RX. Applied logistic regression. John Wiley & Sons; 2013.","DOI":"10.1002\/9781118548387"},{"key":"11135_CR21","doi-asserted-by":"crossref","unstructured":"Narouei A, Rouzbahani NH, Ghanbari M, Taj L, Mohraz M, Gholami M, et al. Expression of mir-221, mir-29a, mir-155 and mir-146a in peripheral blood mononuclear cell (PBMC) in HIV-1 infected patients. Infect Disord Drug Targets Disord. 2021;21(5):62\u20136.","DOI":"10.2174\/1871526520666201207123701"},{"key":"11135_CR22","doi-asserted-by":"crossref","unstructured":"Kapoor R, Arora S, Ponia SS, Kumar B, Maddika S, Banerjea ACJBJ. The MiRNA miR-34a enhances HIV-1 replication by targeting PNUTS\/PPP1R10, which negatively regulates HIV-1 transcriptional complex formation. Biochem J. 2015;470(3):293\u2013302.","DOI":"10.1042\/BJ20150700"},{"key":"11135_CR23","doi-asserted-by":"crossref","unstructured":"Hubert A, Subra C, Jenabian M-A, Labrecque P-FT, Tremblay C, Laffont B, et al. Elevated abundance, size, and MicroRNA content of plasma extracellular vesicles in viremic HIV-1\u2009+\u2009patients: correlations with known markers of disease progression. J Acquired Immune Def Syndrom. 2015;70(3):219.","DOI":"10.1097\/QAI.0000000000000756"},{"key":"11135_CR24","doi-asserted-by":"crossref","unstructured":"Jin C, Cheng L, H\u00f6xtermann S, Xie T, Lu X, Wu H, et al. Micro RNA-155 is a biomarker of T\u2010cell activation and immune dysfunction in HIV\u20101\u2010infected patients. HIV Med. 2017;18(5):354\u20136","DOI":"10.1111\/hiv.12470"},{"key":"11135_CR25","doi-asserted-by":"crossref","unstructured":"Pawar P, Gokavi J, Wakhare S, Bagul R, Ghule U, Khan I, et al. MiR-155 negatively regulates Anti-Viral innate responses among HIV-Infected progressors. Viruses. 2023;15(11):2206.","DOI":"10.3390\/v15112206"},{"key":"11135_CR26","doi-asserted-by":"crossref","unstructured":"Masip J, Gasca-Capote C, Jimenez\u2010Leon MR, Peraire J, Perez\u2010Gomez A, Alba V, et al. Differential miRNA plasma profiles associated with the spontaneous loss of HIV\u20101 control: miR\u2010199a\u20103p and its potential role as a biomarker for quick screening of elite controllers. Clin Transl Med. 2021;11(7).","DOI":"10.1002\/ctm2.474"},{"key":"11135_CR27","doi-asserted-by":"crossref","unstructured":"Rosca A, Anton G, Botezatu A, Temereanca A, Ene L, Achim C, et al. miR-29a associates with viro\u2010immunological markers of HIV infection in treatment experienced patients. J Med Virol. 2016;88(12):2132\u20137.","DOI":"10.1002\/jmv.24586"},{"key":"11135_CR28","doi-asserted-by":"crossref","unstructured":"Patel P, Ansari MY, Bapat S, Thakar M, Gangakhedkar R, Jameel SJR. The MicroRNA miR-29a is associated with human immunodeficiency virus latency. Retrovirol. 2014;11(1):1\u20135.","DOI":"10.1186\/s12977-014-0108-6"},{"key":"11135_CR29","doi-asserted-by":"crossref","unstructured":"Yuan S, Wu Q, Wang Z, Che Y, Zheng S, Chen Y, et al. miR-223: an immune regulator in infectious disorders. Front Immunol. 2021;12:781815.","DOI":"10.3389\/fimmu.2021.781815"},{"key":"11135_CR30","doi-asserted-by":"crossref","unstructured":"Yu T, Ju Z, Luo M, Hu R, Teng Y, Xie L, et al. Elevated expression of miR-146a correlates with high levels of immune cell exhaustion markers and suppresses cellular immune function in chronic HIV-1-infected patients. Sci Rep. 2019;9(1):18829.","DOI":"10.1038\/s41598-019-55100-2"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-11135-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-025-11135-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-11135-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T09:23:24Z","timestamp":1748856204000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-025-11135-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,2]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["11135"],"URL":"https:\/\/doi.org\/10.1186\/s12879-025-11135-7","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,2]]},"assertion":[{"value":"1 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This cross-sectional study was conducted according to the Helsinki declaration. The research received ethical approval from the institutional review boards of the Cape Coast Teaching Hospital (ID no: CCTHERC\/EC\/2022\/017) and the University of Cape Coast (ID no: UCC IRB\/CHAS\/2021\/292). It was ensured that the informed consent of the study participants was sought.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"788"}}